MedPath

ADEVAYA PHARMACEUTICALS PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

TGA:6

Drug Approvals

Adevaya Australia NMN+ 200,000 mcg (407993)

Product Name
Adevaya Australia NMN+ 200,000 mcg
Approval Date
Apr 24, 2023
TGA

Adevaya Australia Eyebright (406898)

Product Name
Adevaya Australia Eyebright
Approval Date
Mar 27, 2023
TGA

Adevaya Australia Neoskin (406899)

Product Name
Adevaya Australia Neoskin
Approval Date
Mar 27, 2023
TGA

Adevaya Australia Hairgro (406903)

Product Name
Adevaya Australia Hairgro
Approval Date
Mar 27, 2023
TGA

Adevaya Australia Immune & Respiratory Health (406343)

Product Name
Adevaya Australia Immune & Respiratory Health
Approval Date
Mar 17, 2023
TGA

Adevaya Australia BeBright (406344)

Product Name
Adevaya Australia BeBright
Approval Date
Mar 17, 2023
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.